China Becomes the Second Largest Plastic Surgery Country and Matrifill ® Ranks No.1 of Domestic Brand
Recently, Sina released the annual big data of medical aesthetics. The data shows that, the total number of medical cosmetic surgery in China exceeded 10 million cases in 2017, more than the figure in Brazil so as to become the second largest medical aesthetics market in the world after the United States. The development of China’s medical aesthetics market in 2017 has attracted worldwide attention.
So far the national CFDA has approved a total of 16 HA dermal filler brands. Among them, Matrifill® was the first in domestic brands and the second among all brands in the world in China’s HA dermal filler brand recognition rank. At the same time, Janlane®, the second-generation Haohai’s HA dermal filler product which was launched in February 2017, also successfully entered the top ten as to the brand recognition.
Pictures of Matrifill ® and Janlane ® products
Since launched in 2014, Matrifill® has made success both in sales volume and reputation. In the first half of 2017, Haohai’s HA dermal filler products revenue reached RMB107 million, a year-on-year increase of over 30%.
Sales incomes of Haohai’s hyaluronic acid products
At last, let’s say congratulations for the big honor received by Matrifill ® and Janlane ® -"2017 Pioneering Medical Aesthetics Brand" from Sina Fashion.
Company News